Anebulo Pharmaceuticals, Inc. (ANEB)

NASDAQ: ANEB · Real-Time Price · USD

1.190

-0.110 (-8.46%)

Apr 1, 2025, 4:00 PM EDT - Market closed

Anebulo Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '25 Apr 1, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Market Capitalization	49	71	60	121	159	-
Market Cap Growth	-29.77%	17.53%	-50.38%	-23.75%	-	-
Enterprise Value	33	66	46	105	159	-
Last Close Price	1.30	2.73	2.35	5.20	6.82	-
PB Ratio	3.57	18.57	5.68	8.06	7.44	-
P/TBV Ratio	2.91	18.57	5.68	8.06	7.44	-
Debt / Equity Ratio	-	-	-	-	-	0.07
Quick Ratio	17.10	11.87	10.52	28.39	82.71	13.53
Current Ratio	17.52	13.46	10.92	30.40	89.61	13.53
Return on Equity (ROE)	-71.49%	-113.80%	-91.42%	-37.42%	-249.85%	-
Return on Assets (ROA)	-42.87%	-65.97%	-54.05%	-22.93%	-18.30%	-
Return on Capital (ROIC)	-46.65%	-72.06%	-57.38%	-23.41%	-18.50%	-
Earnings Yield	-15.95%	-11.58%	-19.48%	-5.62%	-19.00%	-
Buyback Yield / Dilution	-2.48%	-2.98%	-7.41%	-71.49%	-13.44%	-

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q